Biohaven Ltd. Statistics
Want to see BHVN full AI Analyst Report?
Biohaven Ltd. (BHVN) Stock Statistics & Valuation Metrics
Total Valuation
Biohaven Ltd. has a market cap or net worth of $2.28B. The enterprise value is $2.15B.
- Market Cap
- $2.28B
- Enterprise Value
- $2.15B
Share Statistics
Biohaven Ltd. has 151,058,780 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 151,058,780
- Owned by Insiders
- 10.74%
- Owned by Institutions
- 24.00%
Financial Efficiency
Biohaven Ltd.’s return on equity (ROE) is -14.19 and return on invested capital (ROIC) is -218.41%.
- Return on Equity (ROE)
- -14.19
- Return on Assets (ROA)
- -1.64
- Return on Invested Capital (ROIC)
- -218.41%
- Return on Capital Employed (ROCE)
- -2.22
- Revenue Per Employee
- 0
- Profits Per Employee
- -2.70M
- Employee Count
- 274
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Biohaven Ltd. is -3.94. Biohaven Ltd.’s PEG ratio is -0.05.
- PE Ratio
- -3.94
- PS Ratio
- 0.00
- PB Ratio
- -23.35
- Price to FCF
- -4.85
- Price to Operating Cash Flow
- -4.86
- PEG Ratio
- -0.05
Income Statement
In the last 12 months, Biohaven Ltd. had revenue of 0 and earned -738.82M in profits. Earnings per share was -6.86.
- Revenue
- 0
- Gross Profit
- -4.14M
- Operating Income
- -745.38M
- Pretax Income
- -737.38M
- Net Income
- -738.82M
- EBITDA
- -727.46M
- Earnings Per Share (EPS)
- -6.86
Cash Flow
In the last 12 months, operating cash flow was -472.53M and capital expenditures -642,000, giving a free cash flow of -473.17M billion.
- Operating Cash Flow
- -472.53M
- Free Cash Flow
- -473.17M
- Free Cash Flow per Share
- -3.13
Dividends & Yields
Biohaven Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -20.65%
- Earnings Yield
- -23.68%
Stock Price Statistics
- Beta
- 1.59
- 52-Week Price Change
- 78.29%
- 50-Day Moving Average
- 13.62
- 200-Day Moving Average
- 12.28
- Relative Strength Index (RSI)
- 56.70
- Average Volume (3m)
- 3.25M
Important Dates
Biohaven Ltd. upcoming earnings date is Mar 08, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Mar 08, 2027
- Ex-Dividend Date
- ―
Financial Position
Biohaven Ltd. as a current ratio of 3.18, with Debt / Equity ratio of 546.58%
- Current Ratio
- 3.18
- Quick Ratio
- 3.18
- Debt to Market Cap
- 0.20
- Net Debt to EBITDA
- -0.08
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Biohaven Ltd. has paid 1.44M in taxes.
- Income Tax
- 1.44M
- Effective Tax Rate
- -0.00
Enterprise Valuation
Biohaven Ltd. EV to EBITDA ratio is -4.69, with an EV/FCF ratio of -5.28.
- EV to Sales
- 0.00
- EV to EBITDA
- -4.69
- EV to Free Cash Flow
- -5.28
- EV to Operating Cash Flow
- -5.28
Balance Sheet
Biohaven Ltd. has $161.13M in cash and marketable securities with $300.44M in debt, giving a net cash position of -$139.32M billion.
- Cash & Marketable Securities
- $161.13M
- Total Debt
- $300.44M
- Net Cash
- -$139.32M
- Net Cash Per Share
- -$0.92
- Tangible Book Value Per Share
- -$0.78
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Biohaven Ltd. is $25.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $25.00
- Price Target Upside
- 64.58% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 13
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 49.16%
Scores
- Smart Score
- 9
- AI Score
- 56
